Kailera
Cardiometabolic Therapeutics · Prescription Drugs
13open roles
$195kmedian advertised pay
1backers · Atlas Venture
50+team · employees, estimated range
Overview
Kailera is a late clinical-stage biotechnology company advancing a diversified pipeline of GLP-1 therapies to provide options for people living with obesity.
Funding and backers
Team
51-200
employees, estimated range
Hiring now
15
+9 posted in 30 days
Backers
1
Atlas Venture
Momentum
39/100
hiring for its size, in the news
Last sign of life
1 mo ago
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
2024
Founded
Tractionpublic signals, read monthly
Web presence
top 2%
of 133.2M domains by links, Common Crawl
Backed byfrom the funds' portfolios and accelerator catalogs
Investors in similar startupsfunds that back the companies most like this one
backs Sparrow Pharmaceuticals
Similar startupsby what they do, their industry and backers
Akero Therapeutics is a clinical-stage company developing transformational therapies for people with metabolic dysfunction-associated…
Sparrow Pharmaceuticals is an emerging clinical-stage biopharmaceutical company developing novel, targeted therapies for disorders of…
PAhR Therapeutics is a clinical-stage biotech company advancing innovative therapies to treat pulmonary arterial hypertension (PAH) through…
Verdiva Bio is committed to developing next-generation therapies to help people living with obesity, cardiometabolic disorders, and related…
MitoRx is developing new treatments to restore healthy mitochondrial metabolism in patients living with high-risk obesity.
Refoxy Pharmaceuticals GmbH is a pre-clinical biotech company developing FOXO3-targeting therapies to restore cellular balance and treat…
Jobs
$192k – $235k per year · Equity · Hybrid · Full-Time · 10+ years exp · Bachelor's Degree
Smartsheet
Apply
$143k – $175k per year · Equity · Hybrid · Full-Time · 8+ years exp · Bachelor's Degree
GCP
Management
Smartsheet
Apply
$159k – $195k per year · Equity · Hybrid · Full-Time · 5+ years exp · PhD · Waltham
Apply
$192k – $235k per year · Equity · Hybrid · Full-Time · 10+ years exp · Bachelor's Degree
Mass Spectrometry
HPLC
GMP
Apply
$155k – $190k per year · Equity · Hybrid · Full-Time · 10+ years exp · Bachelor's Degree
Smartsheet
Apply
≈ $177k – $307k per year (Estimated) · Equity · Hybrid · Full-Time · 15+ years exp · PhD
GMP
MedTech
ISO 13485
ISO 14971
EU MDR
Design Controls
Design History File
Verification & Validation
ISO 10993
Human Factors Engineering
Apply
$272k – $340k per year · Equity · Hybrid · Full-Time · 15+ years exp
Apply
$155k – $190k per year · Equity · Hybrid · Full-Time · 10+ years exp · Bachelor's Degree
Apply
$143k – $175k per year · Equity · Hybrid · Full-Time · 12+ years exp · PhD · Waltham
HPLC
GMP
MedTech
CAPA
Apply
$155k – $190k per year · Equity · Hybrid · Full-Time · 10+ years exp · Bachelor's Degree
GMP
Apply
≈ $83k – $245k per year (Estimated) · Equity · Hybrid · Full-Time · 15+ years exp · Master's Degree · Waltham
Apply
$400k – $425k per year · Equity · Hybrid · Full-Time · 15+ years exp · Waltham
Apply
Salary insights
Compensation ranges based on this company's open jobs
Median
$195k
Typical range
$175k – $425k
Open positions
13
13
Jobs
Senior
38.5%
Architect
61.5%
| Level | Jobs | Median | Typical range |
|---|---|---|---|
| Senior | 5 | $280k | $175k – $425k |
| Architect | 8 | $195k | $190k – $340k |
Highest paying role
Senior Vice President, Clinical Development
$425k
Normalized to USD per year
All salaries at Kailera
By role, level and city, against the market · 13 jobs with pay
Growth
Hiring Momentum
46/100
Stable
Open positions
15
4 opened / 2 closed in 30 days
Median time-to-fill
65 days
faster than 19% of the market
ATS activity
Every ~5 hours
11/11/2026
Hiring Dynamics
0%
Hiring Focus
The percentage next to each role is its share of the company's job openings over the last 90 days; the arrow shows the shift versus the previous period.
Biotech
50% ▲
Finance
13% ▼
Operations
13% ▼
Leadership
6% ▼
HR
6% ▲
Sales
6% ▲
Actively hiring for Biotech (+6 in 30 days)
Activity Timeline
+3 jobs in a week
Oct 2026
Added GLP to stack
Oct 2026
Added GCP to stack
Oct 2026
Added ISO 10993 to stack
Oct 2026
Added EU MDR to stack
Oct 2026
Added Smartsheet to stack
Oct 2026
Added Mass Spectrometry to stack
Oct 2026
Added CAPA to stack
Oct 2026
Added Oracle ERP to stack
Oct 2026
Added HPLC to stack
Oct 2026
Added GMP to stack
Oct 2026
Added Verification & Validation to stack
Oct 2026
Tech stack
Technologies named in job postings at Kailera over the last 12 months, by layer, with the share of postings for each.
Technologies in use
17
Postings analysed
9
Stack modernity
54/100
Cloud & platforms
GCP
Sign in to see how your skills match this stack
Sign In
Full Kailera tech stack
17 technologies · by team · pay by technology · changes · similar stacks
Connections
List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors
Atlas VentureVia a fund
Click a company to open it. Dashed lines are likely connections. The second step of the network is part of the Pro plan.
Owner
Same company
Same group
Likely
News
Kailera Therapeutics, Inc.(NasdaqGS:KLRA) added to S&P Biotechnology Select Industry Index
Read more
Report
Report
Is Kailera Therapeutics a Buy After Its Sizzling IPO?
There's a new challenger to the more established players in the weight-loss drug space.
Read more
Report
Kailera Therapeutics Announces First Participants Randomized in KaiNETIC Global Phase 3 Clinical Program of GLP-1/GIP Receptor Dual Agonist Ribupatide (KAI-9531)
Read more
Report
$600m round will help Kailera push obesity drug into phase 3
Kailera Therapeutics has raised an eye-watering $600 million in Series B financing to take its lead drug for weight loss into pivotal trials.
Read more
Report
Kailera Therapeutics: $400 Million (Series A) Raised To Advance Next-Gen Therapies For Obesity
Kailera Therapeutics announced its launch as a clinical-stage biopharmaceutical company focused on advancing a broad pipeline of next-generation therapies for treating obesity and related conditions. And Kailera launches with a $400 million Series A finan
Read more
Report
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
1
Countries
1
Busiest office
Waltham
Waltham
United States
HQ
Massachusetts
5 open roles 6 posted in 90 days 20% engineering 50-200 est. staff $269k Avg Salary
hires for Biotech, HR, Science & Research